Use of Medication Technicians in US Nursing Homes: Part of the Problem or Part of the Solution?
Objectives
To determine the relation between organizational characteristics and medication technician (MT) use and quantify the impact of MTs on increasing the likelihood of using medications, employing the example of antiosteoporosis medications.
Design
Cross-sectional study.
Setting
The setting included 6344 Medicare/Medicaid certified nursing homes in 23 states.
Participants
Residents older than 65 years of age.
Measurements
On-line Survey and Certification of Automated Records (OSCAR) provided facility characteristics information including structural, resource, and staffing levels. The Minimum Data Set (MDS) provided information regarding use of antiosteoporosis medications and resident factors. Adjusted estimates of MT use on antiosteoporosis medication use were derived using logistic regression with generalized estimating equations.
Results
MT use varied by state (6.7% in Alaska vs 85% in Kansas). Homes with greater nursing staffing levels per 100 beds (CNA, RN, LPN) were less likely to use MTs, while larger homes, homes using physician extenders, and contracting pharmacy services were more likely to use MTs. Homes with MTs were more likely to have medication error rates of at least 5% (10.1% vs 7.3%) than homes without MTs. After adjustment for resident and facility factors, residents in MT facilities were not more likely to receive antiosteoporosis treatment relative to those in homes without MTs.
Conclusion
These data call into question the use of MTs in nursing homes. Use of MTs may lead to more errors, yet not increase use of medications that are labor intensive to administer.
Keywords: Nursing homes , medication technicians , osteoporosis , drug utilization , On-line Survey and Certification of Automated Records (OSCAR) , Minimum Data Set (MDS)
To access this article, please choose from the options below
Dr Hughes is currently being supported by a National Primary Care Career Scientist award from the Research and Development Office, Northern Ireland. Dr Wright is supported by a postdoctoral T32 training grant from the Agency for Healthcare Research and Quality.All authors were involved in the study concept and design, data analysis and interpretation, and preparation of the manuscript.All authors have no other conflicts of interest.Approved by the ACEP Board of Directors September 2005.
PII: S1525-8610(05)00650-X
doi:10.1016/j.jamda.2005.11.011
© 2006 American Medical Directors Association. Published by Elsevier Inc. All rights reserved.
